Tradestie Institutional Equity Comparison Engine

BSX vs GDT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BSX Overall Edge

BSX Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boston Scientific Corp. (BSX) driven by superior Valuation, Growth & Margin, Options & Structure while GDT counters with relative strength in Momentum & Technical. Fundamentally, BSX trades at 14.0x Forward P/E with 19.6% operating margin (+1.4% YoY revenue) versus GDT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BSX sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro) against GDT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BSX
BSX 14.0x vs GDT N/M Fwd P/E
Growth & Margin Winner BSX
Op Margin 19.6% vs N/A ยท YoY +1.4% vs N/A
Momentum & Technical Winner GDT
1Y -58.4% vs -24.2% ยท 52W Pos 6% vs 0%
Options & Structure Winner BSX
CONSOLIDATION (31st %ile IV) vs UNCLASSIFIED (N/A IV)
BSX NYSE
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
$43.69
-1.47% 1D
Market Cap $64.3B
1M Return -1.58%
1Y Return -58.38%
Forward P/E 14.0x
Unified AI Score
52.9 / 100 HOLD
Tech 49.0 Fund 58.0 Flow 68.0 Mom 60.0
GDT US Equity
GDT
Institutional Equity
$31.31
-0.57% 1D
Market Cap N/A
1M Return -7.89%
1Y Return -24.23%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BSX -58.38% GDT -24.23% Spread: +27.91 pp (GDT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BSX TTM Op. Margin: 19.6% GDT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BSX vs GDT. Trailing 12-month operating profitability (BSX 19.6% vs GDT N/A) and valuation multiples (BSX 14.0x vs GDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BSX (9) vs GDT (1)
Institutional Metric BSX GDT Criterion Row Winner
Market Capitalization Scale $64.3B N/A Larger Scale BSX
Trailing P/E Ratio Valuation 18.7x N/M Lower Multiple BSX
Forward P/E Ratio Valuation 14.0x N/M Lower Multiple BSX
Revenue Growth (YoY) Growth +1.4% N/A Higher Growth BSX
Operating Margin (TTM) Profitability 19.6% N/A Higher Margin BSX
Net Profit Margin Profitability 16.6% N/A Higher Margin BSX
Return on Equity (ROE) Capital Efficiency 14.1% N/A Higher ROE BSX
52-Week Range Position Momentum 6% ($40โ€“$106) 0% ($31โ€“$46) Stronger Trend BSX
Beta / 30D Volatility Risk Regime 0.32ฮฒ ยท 45% Vol 0.76ฮฒ ยท 24% Vol Lower Realized Risk GDT
Unified Institutional Score Composite Signal 52.9 / 100 (HOLD) 45.5 / 100 (HOLD) Higher Composite BSX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BSX vs GDT Buy Guide
BSX CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BSX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GDT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BSX nor GDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.